https://www.mangaloremirror.com/ipsen-esmo-2021-cabometyx-demonstrates-sustained-78-reduction-in-risk-of-disease-progression-or-death-in-people-living-with-uncommon-form-of-thyroid-cancer/
Ipsen: ESMO 2021: Cabometyx® Demonstrates Sustained 78% Reduction in Risk of Disease Progression or Death in People Living With Uncommon Form of Thyroid Cancer